Financials Samsrita Labs Limited

Equities

DRHABEEB

INE579N01018

Healthcare Facilities & Services

Delayed Bombay S.E. 06:00:58 2024-07-16 am EDT 5-day change 1st Jan Change
17.17 INR -1.27% Intraday chart for Samsrita Labs Limited +1.60% -0.92%

Valuation

Fiscal Period: Marzo 2018 2019 2020 2021 2022 2023
Capitalization 1 509.3 428.1 844.1 646.4 422 331.4
Enterprise Value (EV) 1 573.9 507 929.6 740.2 449.4 352.1
P/E ratio -47.5 x -16.9 x -42 x -83.2 x 28.2 x -46.6 x
Yield - - - - - -
Capitalization / Revenue 82.6 x 21.2 x 59 x 4,983 x 1,880 x 1,527 x
EV / Revenue 93 x 25.2 x 64.9 x 5,706 x 2,001 x 1,623 x
EV / EBITDA -50.9 x -20.8 x -42.5 x -79.4 x -112 x -35.7 x
EV / FCF -23 x -13.7 x -61.8 x -112 x -20.3 x 48.2 x
FCF Yield -4.34% -7.28% -1.62% -0.89% -4.92% 2.07%
Price to Book 4.77 x 3.51 x 7.16 x 5.8 x 3.19 x 2.65 x
Nbr of stocks (in thousands) 11,059 13,809 14,809 14,809 14,809 14,809
Reference price 2 46.05 31.00 57.00 43.65 28.50 22.38
Announcement Date 8/27/18 9/3/19 12/2/20 8/20/21 8/25/22 9/6/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Marzo 2018 2019 2020 2021 2022 2023
Net sales 1 6.167 20.14 14.32 0.1297 0.2245 0.217
EBITDA 1 -11.27 -24.4 -21.86 -9.323 -4.025 -9.871
EBIT 1 -11.39 -24.59 -22.03 -9.444 -4.079 -9.908
Operating Margin -184.73% -122.05% -153.83% -7,279.69% -1,816.47% -4,565.9%
Earnings before Tax (EBT) 1 -11.11 -23.48 -20.53 -8.016 14.98 -7.072
Net income 1 -10.36 -22.31 -19.82 -7.767 14.98 -7.072
Net margin -167.93% -110.75% -138.4% -5,987.11% 6,673.12% -3,258.9%
EPS 2 -0.9698 -1.833 -1.357 -0.5245 1.010 -0.4800
Free Cash Flow 1 -24.92 -36.92 -15.04 -6.599 -22.11 7.302
FCF margin -404.12% -183.26% -105.02% -5,086.95% -9,846.31% 3,364.79%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 8/27/18 9/3/19 12/2/20 8/20/21 8/25/22 9/6/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: Marzo 2018 2019 2020 2021 2022 2023
Net Debt 1 64.6 79 85.5 93.8 27.3 20.7
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -5.731 x -3.235 x -3.913 x -10.06 x -6.786 x -2.097 x
Free Cash Flow 1 -24.9 -36.9 -15 -6.6 -22.1 7.3
ROE (net income / shareholders' equity) -7.62% -14.6% -12.4% -5.02% 12.3% -5.49%
ROA (Net income/ Total Assets) -3.38% -6.26% -5.06% -2.08% -1.51% -3.79%
Assets 1 306.5 356.6 391.8 374.1 -990.6 186.7
Book Value Per Share 2 9.660 8.840 7.960 7.530 8.930 8.450
Cash Flow per Share 2 0.2900 0.0200 0.0200 0.0100 0.0100 0
Capex 1 11.9 15.5 11.1 3.41 - -
Capex / Sales 192.8% 76.95% 77.8% 2,630.97% - -
Announcement Date 8/27/18 9/3/19 12/2/20 8/20/21 8/25/22 9/6/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. DRHABEEB Stock
  4. Financials Samsrita Labs Limited